Anupam Dalal
Direktor/Vorstandsmitglied bei AADI BIOSCIENCE, INC.
Vermögen: 3 Mio $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Anupam Dalal
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 31 | |
| Public Company | Biotechnology | 19 | |
Acuta Capital Partners LLC
 Acuta Capital Partners LLC Financial ConglomeratesFinance Acuta Capital Partners LLC (ACP) is a registered investment adviser and hedge fund manager headquartered in Belmont, California. Formerly known as Longwood Capital Partners LLC, the firm was founded in 2011 and is a subsidiary of The Lin-Lay 2007 Trust. ACP provides investment management services, directly or through their affiliates, to several privately-offered, as well as to a separately managed account for a high-net worth individual.
8
| Subsidiary | Financial Conglomerates | 8 |
Aadi Subsidiary, Inc.
 Aadi Subsidiary, Inc. BiotechnologyHealth Technology Aadi Subsidiary, Inc. engages in biopharmaceutical company. Its therapeutic programs include pulmonary arterial hypertension, pediatric solid tumors, solid tumors with mTOR activation and mitochondrial disease. The company was founded by Neil Desai and is headquartered in Pacific Palisades, CA.
8
| Subsidiary | Biotechnology | 8 |
Aerpio Therapeutics, Inc.
 Aerpio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. The firm develops small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Its two lead programs include a tie-2 activator for diabetic macular edema and vascular leak, and a hypoxia-inducible factor 1-a stabilizer for wound healing and the treatment of inflammatory bowel disease. The company was founded by Joseph H. Gardner and Robert Shalwitz in 2011 and is headquartered in Cincinnati, OH.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Kearny Venture Partners
 Kearny Venture Partners Investment ManagersFinance Kearny Venture Partners (Kearny Venture Partners) is a venture capital firm. The firm is headquartered in San Francisco, California.
4
| Private Company | Investment Managers | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Anupam Dalal
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Comptroller/Controller/Auditor General Counsel Human Resources Officer Chief Operating Officer | |
| IMMUNOMEDICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member Chairman Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
Healthquest Capital Management Co LLC
 Healthquest Capital Management Co LLC Investment ManagersFinance HealthQuest Capital Management Co LLC (HealthQuest Capital ) is a private equity firm founded in 2013 by Garheng Kong. The firm is headquartered in Redwood City, California. | Investment Managers | Director of Finance/CFO Private Equity Investor Director of Finance/CFO | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| University of Michigan | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| CELGENE | Biotechnology | General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
| Suffolk University | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin | |
| KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Director of Finance/CFO Chairman President | |
Procter & Gamble Pharmaceuticals, Inc.
 Procter & Gamble Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Procter & Gamble Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its products include Actonel, Asacol, Enablex, Didronel, Macrobid, Macrodantin, Entex, and Ziac. The firm manufactures and markets a variety of over-the-counter and oral care products such as Crest, Oral-B, Prilosec OTC, Vicks, Metamucil, Pepto-Bismol, ThermaCare, and other related products. The company was founded in 1970 and is headquartered in Cincinnati, OH. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Calvert Capital Management Co.
 Calvert Capital Management Co. Investment ManagersFinance Calvert Capital Management Co. (Calvert Capital Management) is a venture capital firm founded in 1982. The firm is headquartered in Waltham, Massachusetts. | Investment Managers | Founder Private Equity Investor | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
TriVascular, Inc.
 TriVascular, Inc. Medical SpecialtiesHealth Technology TriVascular, Inc. develops and manufactures medical devices. It provides devices and procedures for treating abdominal aortic aneurysms and endovascular grafts. The company was founded by Michael V. Chobotov, Robert G. Whirley, and Joseph W. Humphrey in 1998 and is headquartered in Irvine, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
| CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Kanyos Bio, Inc.
 Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Anokion SA
 Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Medical/Nursing Services | Director/Board Member Chairman | |
| VISA, INC. | Miscellaneous Commercial Services | Director/Board Member Private Equity Analyst | |
NewBridge Pharmaceuticals FZ LLC
 NewBridge Pharmaceuticals FZ LLC Pharmaceuticals: MajorHealth Technology NewBridge Pharmaceuticals FZ LLC engages in the manufacture and distribution of pharmaceutical products, therapeutics and medical devices. The company was founded by G. Garrett Vygantas in 2007 and is headquartered in Dubai, United Arab Emirates. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of California San Diego | College/University | Doctorate Degree Undergraduate Degree | |
Novartis Venture Funds (USA)
 Novartis Venture Funds (USA) Investment ManagersFinance Founded in 1996, Novartis Venture Funds (USA) is a venture capital firm located in Cambridge, Massachusetts. The firm is a subsidiary of Switzerland-based Novartis Venture Funds and their ultimate parent is Novartis AG, a Switzerland-based company that engages in the research, development, manufacturing and marketing of healthcare products. Novartis Venture Funds manages the Bermuda domiciled biotechnology venture fund, Novartis BioVentures Ltd | Investment Managers | Private Equity Investor Private Equity Investor | |
| MERUS N.V. | Biotechnology | Director/Board Member Director/Board Member | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Novo Ventures 1 A/S
 Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Private Equity Investor Private Equity Investor | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| Massachusetts College of Liberal Arts | College/University | Undergraduate Degree Undergraduate Degree | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
| MEDIVATION INC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Operating Officer | |
| ATARA BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman General Counsel | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree | |
JDRF International
 JDRF International Miscellaneous Commercial ServicesCommercial Services JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
| Providence College | College/University | Masters Business Admin Undergraduate Degree | |
| ANNEXON, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
APP Pharmaceuticals, Inc.
 APP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology APP Pharmaceuticals, Inc. develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. It offers one of the most comprehensive product portfolios used in hospitals, long-term care facilities, alternate care sites and clinics within North America and manufactures a comprehensive range of dosage formulations. The company is headquartered in Los Angeles, CA. | Pharmaceuticals: Major | Chief Administrative Officer General Counsel | |
| PTC THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| AURA BIOSCIENCES, INC. | Biotechnology | Director of Finance/CFO Chief Operating Officer |
Statistik
International
| Vereinigte Staaten | 44 |
| Dänemark | 4 |
| Irland | 2 |
| Schweiz | 2 |
| Vereinigte Arabische Emirate | 2 |
Sektoral
| Health Technology | 32 |
| Consumer Services | 10 |
| Finance | 8 |
| Commercial Services | 3 |
| Health Services | 2 |
Operativ
| Director/Board Member | 285 |
| Corporate Officer/Principal | 143 |
| Independent Dir/Board Member | 82 |
| Undergraduate Degree | 58 |
| Director of Finance/CFO | 53 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Jack Nielsen | 38 |
| Muneer Satter | 35 |
| Michael Wyzga | 31 |
| Richard Maroun | 27 |
| John M. Rice | 27 |
| Ronald Renaud | 24 |
| Caley Castelein | 23 |
| Maxine Gowen | 23 |
| Campbell Murray | 23 |
| Karin Hehenberger | 21 |
| Cheryl L. Cohen | 20 |
| Emma Reeve | 18 |
| Scott Canute | 17 |
| Jim M. Shapiro | 16 |
| William F. Daly | 15 |
- Börse
- Insiders
- Anupam Dalal
- Unternehmensverbindungen
